Distinct differences in platelet production and function between neonates and adults: implications for platelet...

Area of Science:

• Neonatal Medicine
• Hematology
• Transfusion Medicine

Background:

• Thrombocytopenia is prevalent in sick neonates, particularly preterm infants who face higher risks of hemorrhage.
• Current prophylactic platelet transfusion practices in neonates are often liberal and lack strong evidence, influenced by in vitro observations of neonatal platelet hyporeactivity.
• Cardiorespiratory issues are primary drivers of intraventricular hemorrhage in neonates.

Purpose of the Study:

• To review developmental differences in platelet production, function, and primary hemostasis in preterm and term neonates.
• To discuss the implications of these developmental variations for transfusion medicine.
• To highlight the need for evidence-based guidelines for platelet transfusions in premature infants.

Main Methods:

• Review of existing literature on neonatal platelet physiology and hemostasis.
• Analysis of factors influencing platelet function and transfusion thresholds.
• Discussion of the impact of illness and developmental stage on hemostatic profiles.

Main Results:

• Neonatal platelets may be hyporeactive in vitro, but full-term infants often show normal to enhanced primary hemostasis.
• Developmental differences in platelet production and function exist between preterm and term neonates.
• Significant disparities in current platelet transfusion practices are observed globally.

Conclusions:

• A deeper understanding of neonatal platelet function and hemostasis is crucial for refining transfusion strategies.
• Randomized controlled trials are necessary to establish optimal platelet transfusion thresholds for premature infants.
• Standardizing transfusion practices requires further research into the unique hemostatic profiles of neonates.